🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are delighted to welcome Dr Caroline Mitchell @dclovesgp as co-lead of our cancer research theme on cancer prevention & early diagnosis, with Nick Latimer. With a better understanding of cancer in Yorkshire, we can develop targeted interventions & screening to improve survival.

New paper just out: we tend to always use the Hazard Ratio as population-level summary measure in clinical trials with survival outcomes. Is that always justified? [1/N] @tmorris_mrc Ian White Max Parmar journals.sagepub.com/doi/10.1177/17…

A review of survival extrapolation methods with external evidence finds lots of methods, but little in the way of validation #hta #survivalanalysis Ash Bullement Gianluca Baio @gemmaeshields Nick Latimer @ScHARRHEDS UCL Statistical Science HealthEcon_MCR bit.ly/423tcJG

I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code. Huge thanks to Mark Rutherford Dan Jackson Nick Latimer Paul Lambert and all co-authors doi.org/10.1177/027298…

Nice summary of our session ‘EHR - a good target’ which focussed on research design and methodologies for working with EHR. Great turnout and discussion #RSS2023Conf linkedin.com/posts/internat…

A big day 🤩 We've also launched: 👩‍🏫 A free course in survival analysis on our new Youtube channel 💻 A new #Stata package called #morgana for Bayesian flexible survival analysis 🧐 An advert for a new Principal Biostatistician to join the team #Biostatistics

12 days left until #HWSmethods2023 in Universität Mainz! Check out the program👇 with keynotes from Noemi Kreif and Nick Latimer. You can still register via [email protected] - no participation fees thanks to DG Epidemiologie, GMDS e.V., IBS, @DGSMP_e_V. #EpiTwitter #StatsTwitter

***Fully Funded PhD Studentships*** We have 7 Wellcome Studentships in Public Health Economics and Decision Science available. Check out our website for more information: pheds-dtc.ac.uk Deadline: 11th December 2023

📣 This time next week #ISPOREurope will be in full swing. 🔗 take a look at SCHARR's full academic programme buff.ly/3F5nwpb 😀 We hope you’ll pop by to see us on stand C2-021 in Hall E SCHARR HEDS SCHARR ISPOR #ISPOR2023

📜Paper📜 in Brain and Behavior with Keith R Abrams, Nick Latimer, Michela Guglieri, Mark Rutherford and Michael Crowther. Assessing the CPRD as a data resource for DMD (and other rare disease) natural history models: ✅ Mortality ❓ Intermediate events doi.org/10.1002/brb3.3… #rarediseases

We are seeking leading cancer researchers to come & join us at Sheffield, in partnership with Sheffield Hospitals. You'll have a package of support inc research staff, consumables & PhD(s) + access to dedicated funding opportunities through Yorkshire Cancer Research 👉cancer-research-sheffield.co.uk

Some really great opportunities at Sheffield at the moment, including for methodologists.

If you're too busy to read 4000 words on moving data between countries, listen to my quick summary of key points in the video below. Vivek Subbiah, MD Nick Latimer #oncology

Research by Nick Latimer and colleagues shows that forcing a marginal hazard ratio to 1 does not accurately assess mean survival difference under individual-level treatment effect waning. More at ow.ly/gHFY50QO0yc. #HEOR #HTA #harzardratio #ValueinHealth

A publication from my doctoral work with my fantastic and inspiring supervisors Prof Nick Latimer Nick Latimer and Prof Jim Chilcott, and sponsored by the generous Wellcome. SCHARR SCHARR HEDS #HTA #treatmentsequennces #RWD #causalinference

🚨 Helpful how-to evaluate treatment sequences for #HTA by SCHARR Amy Chang Nick Latimer pharmacoeconomics #pharmacoeconomics link.springer.com/article/10.100…

Treatment switching in randomised controlled trials: Trial design, what to adjust for, how, and reporting guidelines. The DSU’s new TSD 24 provides an update to TSD 16 – out now! shorturl.at/uJKMO

We are currently advertising for an early career researcher with a strong background in statistics/mathematics and an interest in Bayesian statistics and health technology assessment to join us at SCHARR G7, fixed-term until 31 March 2028 jobs.shef.ac.uk/sap/bc/webdynp…

Cure Models for HTA: What You Need to Know Should decision-makers be more willing to use cure models? How do they work? What can go wrong? What on earth are flexible parametric non-mixture cure models??! Thanks to Mark Rutherford for writing this with me. link.springer.com/article/10.100…

👩‍🏫 Join us at the #ISPORSummit for Prof. Nick Latimer's Nick Latimer talk on "Methods for Causal Inference Using Real-World Data " 📅 Sunday 17 November, 13:15 - 14:50. 💭 Enhance your #RWE knowledge with this insightful conversation. 🔗 buff.ly/3UGSSe2